Magny Romain, Beauxis Yann, Genta-Jouve Gregory, Bourgogne Emmanuel
Laboratoire de Toxicologie, Fédération de Toxicologie, AP-HP, Hôpital Lariboisière, 75006, Paris, France.
Université Paris Cité, CNRS, CiTCoM, 75006, Paris, France.
Heliyon. 2024 Aug 31;10(17):e36735. doi: 10.1016/j.heliyon.2024.e36735. eCollection 2024 Sep 15.
In toxicology, LC-HRMS for untargeted screening yields a great deal of high quality spectral data. However, there we lack tools to visualize/organize the MS data. We applied molecular networking (MN) to untargeted screening interpretation. Our aims were to compare theoretical MS libraries obtained with our experimental dataset in patients to broaden its application, and to use the MetWork web application for metabolite identification.
Samples were analyzed using an LC-HRMS system. For MN, data was generated using MZmine, and analyzed and visualized using MetGem. MetWork annotations were filtered and this file was used for annotation of the previously obtained MN.
155 compounds including drugs found in patients were recorded. Using this dataset, we confirmed in 60 patients intake of tramadol, amitriptyline bromazepam, and cocaine. The results obtained by the reference methods were confirmed by MN approaches. Eighty percent of the compounds were common to both conventional and MN approaches. Using MetWork, metabolites and parent drugs such as amitriptyline, its metabolite nortriptyline and amitriptyline glucuronide phase 2 metabolites were anticipated and proposed as putative annotations.
The workflow increases confidence in toxicological screening by highlighting putative structures in biological matrices in combination with CFM-ID (Competitive Fragmentation Modeling for Metabolite Identification) and MetWork to extend the annotation of potential drugs even without a reference standard.
在毒理学中,用于非靶向筛查的液相色谱 - 高分辨质谱(LC - HRMS)可产生大量高质量的光谱数据。然而,我们缺乏可视化/整理质谱数据的工具。我们将分子网络(MN)应用于非靶向筛查解读。我们的目的是将患者实验数据集获得的理论质谱库进行比较,以拓宽其应用范围,并使用MetWork网络应用程序进行代谢物鉴定。
使用LC - HRMS系统分析样品。对于分子网络,数据使用MZmine生成,并使用MetGem进行分析和可视化。对MetWork注释进行筛选,并将此文件用于先前获得的分子网络的注释。
记录了155种化合物,包括在患者体内发现的药物。使用该数据集,我们在60名患者中确认了曲马多、阿米替林、溴西泮和可卡因的摄入情况。参考方法获得的结果通过分子网络方法得到了证实。80%的化合物在传统方法和分子网络方法中是相同的。使用MetWork,预测并提出了代谢物和母体药物,如阿米替林、其代谢物去甲替林和阿米替林葡萄糖醛酸结合物等II相代谢物作为假定注释。
该工作流程通过结合CFM - ID(代谢物鉴定的竞争碎片建模)和MetWork突出生物基质中的假定结构,增强了毒理学筛查的可信度,即使没有参考标准也能扩展潜在药物的注释。